Gynecologic Cancer
News for Your Practice
In women under 50 years, mammography detects smaller tumors than clinical examination does
New data reveals that mammographically identified tumors are smaller and less likely to have nodal involvement in women 40 to 49 years old
Expert Commentary
Is population-based screening for endometrial cancer feasible?
Expert Commentary
When is endocervical curettage informative in cervical cancer screening?
From the Editor
Consider denosumab for postmenopausal osteoporosis
Easy to use and effective, this recently approved agent appears well suited to ObGyn office practice
Expert Commentary
Can nonhormonal treatments relieve hot flushes in breast Ca survivors?
Yes. A Cochrane Review found clonidine, selective serotonin reuptake inhibitors (SSRIs), selective norepinephrine reuptake inhibitors (SNRIs),...
News for Your Practice
Quadrivalent HPV vaccine now FDA-approved to prevent anal cancer
Most cases of anal cancer are diagnosed in women. HPV vaccination may prevent cancer or limit the burden of disease, the agency declares
Clinical Review
Skilled US imaging of the adnexae: Ovarian Neoplasms
Not all neoplasms represent cancer, and some have overlapping sonographic characteristics. Here’s what you need to know to differentiate what is...
Expert Commentary
Just how much does screening mammography reduce mortality from breast cancer?
2%. That’s the percentage for women 50 to 69 years old, according to a sophisticated observational study from Norway. Kalager M, Zelen M,...
Clinical Review
An ObGyn’s guide to aromatase inhibitors as adjuvant therapy for breast CA
You may not prescribe anastrozole, letrozole, or exemestane, but there’s a strong possibility that some of your patients are taking one of these...
News for Your Practice
New study reveals a link between estrogen-progestin HRT and advanced breast cancer
Data from the Women’s Health Initiative show that mortality is higher in postmenopausal women who develop breast cancer after taking combined...
Clinical Review
2 HPV vaccines, 7 questions that you need answered
The availability of two vaccines against human papillomavirus raises numerous questions about fine points of cervical cancer prevention